Large-dose Hydroxyethyl Starch 130/0.4 Does Not Increase Blood Loss and Transfusion Requirements in Coronary Artery Bypass Surgery Compared with Hydroxyethyl Starch 200/0.5 at Recommended Doses

2003 ◽  
Vol 99 (1) ◽  
pp. 42-47 ◽  
Author(s):  
Stefan-Mario Kasper ◽  
Philipp Meinert ◽  
Sandra Kampe ◽  
Christoph Görg ◽  
Christof Geisen ◽  
...  

Background Hydroxyethyl starch (HES) 130/0.4 may impair blood coagulation less than other HES solutions and, thus, may be used at larger doses without increasing the risk of postoperative bleeding. This study tested the hypothesis that volume replacement with 6% HES 130/0.4 at a dose of up to 50 ml/kg does not increase blood loss and transfusion requirements in elective coronary artery bypass surgery compared with 6% HES 200/0.5 at a dose of up to 33 ml/kg. Methods One hundred twenty adult patients scheduled for elective coronary artery bypass surgery were randomized to receive up to 50 ml/kg of 6% HES 130/0.4 or up to 33 ml/kg of 6% HES 200/0.5 for volume replacement during surgery and until 24 h thereafter. Volume requirements in excess of the respective maximum dose of HES were treated with gelatin. Colloid use was at the discretion of the attending physicians and not dictated by protocol. The primary outcome variable was chest tube drainage volume during the first 24 h after surgery. Results The data from 117 patients (HES 130/0.4, 59 patients; HES 200/0.5, 58 patients) who completed the study according to protocol were analyzed. The median volumes of HES administered were 49 and 33 ml/kg in the HES 130/0.4 and HES 200/0.5 groups, respectively (P < 0.001). Consequently, patients in the HES 130/0.4 group required less gelatin in addition to HES than those in the HES 200/0.5 group (medians: 7 ml/kg vs. 20 ml/kg, P < 0.001). The combined volumes of HES and gelatin were similar for both groups (P = 0.21). The 24-h chest tube drainage (medians: 660 ml vs. 705 ml, P = 0.60) did not differ significantly between the groups, nor did transfusion outcome. Conclusion Six percent HES 130/0.4 at a median dose of 49 ml/kg did not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with 6% HES 200/0.5 at a median dose of 33 ml/kg.

2001 ◽  
Vol 95 (1) ◽  
pp. 81-86 ◽  
Author(s):  
Stefan-Mario Kasper ◽  
Thorsten Giesecke ◽  
Peter Limpers ◽  
Rainer Sabatowski ◽  
Uwe Mehlhorn ◽  
...  

Background Previous studies failed to demonstrate any benefit from prophylaxis with fresh frozen plasma (FFP) after cardiopulmonary bypass (CPB). The results, however, were limited by either retrospective study design or use of FFP in subtherapeutic doses (2-3 units). The authors evaluated whether a therapeutic dose (15 ml/kg) of FFP reduces blood loss and transfusion requirements in elective coronary artery bypass surgery. The risks of multiple allogeneic blood donor exposure were circumvented by using autologous plasma. Methods Sixty adult patients scheduled for elective primary coronary artery bypass grafting were randomized to receive, after CPB, an intravenous infusion of 15 ml/kg of either autologous FFP (30 patients) or 6% hydroxyethyl starch 450/0.7 (HES; 30 patients). Autologous plasma was obtained by platelet-poor plasmapheresis several weeks before surgery. Perioperative blood transfusions were administered per protocol. Postoperative blood loss was defined as the chest tube drainage during the first 24 h after surgery. Results The data from 56 patients (FFP group, 27 patients; HES group, 29 patients) who completed the study according to protocol were analyzed. Median postoperative blood loss was 630 ml (range, 450-1,840 ml) and 830 ml (range, 340-1,980 ml) in the FFP and HES groups, respectively (P = 0.08). Both postoperative (0-24 h) and total perioperative erythrocyte transfusion requirements did not differ significantly between the groups (P = 0.32 and 0.14, respectively). Conclusion The prophylactic administration of a therapeutic dose (15 ml/kg) of autologous FFP after CPB failed to reduce blood loss and transfusion requirements in patients undergoing uncomplicated, elective, primary coronary artery bypass surgery.


2004 ◽  
Vol 78 (5) ◽  
pp. 1536-1541 ◽  
Author(s):  
Michael W.A. Chu ◽  
Steve R. Wilson ◽  
Richard J. Novick ◽  
Larry W. Stitt ◽  
MacKenzie A. Quantz

2009 ◽  
Vol 23 (3) ◽  
pp. 312-315 ◽  
Author(s):  
Reza Jalaeian Taghaddomi ◽  
Asadollah Mirzaee ◽  
Alireza Sharifian Attar ◽  
Abbas Shirdel

Shock ◽  
2014 ◽  
Vol 41 (3) ◽  
pp. 193-199 ◽  
Author(s):  
Vladimir V. Lomivorotov ◽  
Evgeny V. Fominskiy ◽  
Sergey M. Efremov ◽  
Valeriy A. Nepomniashchikh ◽  
Vladimir N. Lomivorotov ◽  
...  

2014 ◽  
Vol 8 (2) ◽  
pp. 224 ◽  
Author(s):  
AliAkbar Rahimianfar ◽  
MohammadHassan Abdollahi ◽  
MohammadHossein Moshtaghiyoon ◽  
Mahdi Haddadzadeh ◽  
Asefeh Fekri ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document